HC Wainwright & Co. reiterated coverage on Sorrento Therapeutics with a new price target

8/9/21 6:25:18 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

HC Wainwright & Co. reiterated coverage of Sorrento Therapeutics with a rating of Buy and set a new price target of $26.00 from $30.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SRNE

Date	Price Target	Rating	Analyst
11/2/2022	$5.00	Overweight	Cantor Fitzgerald
8/9/2021	$30.00 → $26.00	Buy	HC Wainwright & Co.